This research investigates β-caryophyllene, a natural compound found in black pepper, as a protective treatment for diabetic kidney disease. The compound shields kidney cells from high-glucose damage, offering a promising, safe, plant-based therapeutic pathway for preventing diabetic nephropathy and improving long-term outcomes for patients.

PCBs, toxic “forever chemicals” found in older school buildings, accumulate in body fat and trigger harmful inflammation. This research shows that PCB-exposed fat cells recruit excessive immune cells, creating an uncontrolled inflammatory response that contributes to obesity and diabetes. Understanding this mechanism opens pathways for treatments targeting fat–immune cell communication.

This research investigates how different low-calorie sweeteners interact with the body’s sweet-taste receptor and influence biochemical signaling. By measuring the molecular “messenger” responses triggered by various sweeteners, the project aims to identify which ones have healthier metabolic effects, supporting better choices for weight management, diabetes, and general well-being.

Type 1 diabetes destroys insulin-producing cells, leaving patients dependent on lifelong injections. Islet transplants could provide freedom, but most cells die quickly. This research uses drug-loaded microparticles that protect transplanted islets, boosting survival, insulin production, and diabetes reversal. The approach could cut costs, reduce donor needs, and transform treatment for multiple diseases.